Amit Agarwal

Hem/Onc doc, Passionate about bringing novel drugs to oncology patients... doing it now as a biotech executive... views my own.

[David Steensma, MD @DavidSteensma]

With the disappointing announcement today by @abbvie of the negative result of the VERONA venetoclax/azacitidine trial, that brings the tally to (by my count) 17 consecutive negative randomized drug trials in higher-risk #MDSsm. This is a slide I made summarizing them./1

[Amit Agarwal @agarwalonc]

@NitinJainMD whoa... that is quite a site... stay safe!

[Amit Agarwal @agarwalonc]

Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells - The Lancet https://t.co/KKMOI9Y5Ro

[Amit Agarwal @agarwalonc]

@szusmani @cricketworldcup @sridevirajeeve @hhashmi87 This was an awesome experience.. @szusmani I wish you were at Nassau ground!!! Amazing atmosphere!!!

[James Zou @james_y_zou]

We used #GPT4 to greatly simplify medical consent forms for patients in new @NEJM_AI paper https://t.co/mSrgMFCAV3 Our #LLM simplified forms are now used in the largest health system in Rhode Island.

Medical documents like consent forms are often hard to understand--great use case for LLM. We had medical + legal experts review the simplified forms to ensure accuracy.

Great job led by @RohaidAliMD Fatima Mirza @oliverytang @IDavidConnolly and wonderful collaborators! 🚀

[Amit Agarwal @agarwalonc]

@Rfonsi1 Just like ICD codes!!!

[Amit Agarwal @agarwalonc]

@JoshuaRichterMD @aamdsif @RahulBanerjeeMD well done...

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC review: Therapeutic avenues for γδ T cells in cancer https://t.co/2ZKCQlW636 @BSilva_Santos

[Amit Agarwal @agarwalonc]

Very interesting!!! #mmsm #BCMA
https://t.co/f4WhJHqUW7

[Amit Agarwal @agarwalonc]

@Phari @kansagraMD @MrinalPatnaik @AbhiTrip87 @jaimtriv @DrPMPGI @BldCancerDoc @AjayNookaMD Agree!!! As an Indian fan- it is great to see the total domination!!! This was considered a ‘close’ game and we won by 70 runs 😂

[NEJM @NEJM]

In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: https://t.co/sHpHQFOGLu

#AHA23 @AHAScience

[Daphne Zohar @daphnezohar]

Diwali honors the victory of light over darkness, good over evil, and knowledge over ignorance.

Wishing all my friends who observe #Diwali and to all the world - a victory of light, good and knowledge during this dark & divisive time.

#Diwali2023 #Deepavali

[Amit Agarwal @agarwalonc]

@JoshuaRichterMD @TischCancer @MountSinaiNYC True inspiration for so many of us!!!

[Amit Agarwal @agarwalonc]

@drkomanduri Median of $2500 for an auto 😲$10000 for an allo 😲😲😲

[Hemalatha Rangarajan MD https @hmgcoa2]

Listened 2 an inspiring talk by Prof Mamta VijayManglani @ 2nd Emirates peds bmt conference Govt hospital Mumbai, Borivalli BMT center median cost Allo 9184$, auto 2487$ #hct for the poor & the masses! 300 & counting....that's what I call impact..#HCT for all who need it

[Amit Agarwal @agarwalonc]

@kansagraMD @MrinalPatnaik @AbhiTrip87 @Phari @jaimtriv @DrPMPGI @BldCancerDoc @AjayNookaMD Imagine if India play Afghanistan in the semis… who would have thought…
This has to be the best India team ever!

[Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 @BLLPHD]

Deletion of the inhibitory co-receptor CTLA4 enhances and invigorates chimeric antigen receptor T cells #immunotherapy #CARTCell #tcellrx
https://t.co/0fOQbJ5lPl

[Amit Agarwal @agarwalonc]

Such a stellar group- very well deserved!!!

[Myeloma Society @Myeloma_Society]

Congratulations to this year's award recipients! Join us on Thursday, September 28 at 9:00 am during #IMS23 for the award ceremony.

[Amit Agarwal @agarwalonc]

I remember this one like yesterday... this is one of my favorite @sachin_rt ODI innings... and there are many!!!
https://t.co/8CNxpkMTmE